Corruptie in het nieuws.

Integrity in Business: Key for sustainable and long term prosperity

TI-Romania-Conference held in Bucharest, 27-29 November 2013, Round table: Corporate Good Governance Dr Michel van Hulten, Professor Governance SAXION School of Governance, Law and Urban Studies Enschede / Deventer, the Netherlands michelvanhulten@planet.nl; m.h.m.vanhulten@saxion.nl www.corruptie.org; www.saxion.edu ‘The purpose of this three-day conference is to debate why companies should take integrity seriously and engage their stakeholders to work … Lees meer

Handbook for Business

Go to Union Jack → Publications → to see the → OECD – UNODC – World Bank Anti-Corruption Ethics and Compliance Handbook for Business (128 pages, 1 December 2013).

Siemens and the battle against bribery and corruption

130918-20, Siemens at UN Leaders summit Siemens and the battle against bribery and corruption “Sustainability is about survival,” says Siemens general counsel Peter Solmssen, who argues that global cooperation is key to winning the fight • Peter Solmssen, general counsel for Siemens, is speaking at the UN Global Compact Leaders Summit on 20 September. Bruce … Lees meer

GlaxoSmithKline & Wheel-greasing in China and in the USA

130907, GlaxoSmithKline & Wheel-greasing in China and in the USA http://www.fcpaprofessor.com/friday-roundup-91?goback=%2Egde_135508_member_271576048#%21 September 6th, 2013 [also GlaxoSmithKline] FROM: FCPA Professor, A Forum devoted to the Foreign Corrupt Practices Act (visited 8 Sept. 2013). Hardly a Smoking Gun Reuters and other media outlets have carried forward Chinese state media reports as follows.  “A Chinese police investigation into … Lees meer

Beijing weighing large fines against GlaxoSmithKline

130904, China and GlaxoSmithKline Beijing weighing large fines against GlaxoSmithKline Government accused drugmaker of creating a culture that encouraged widespread bribery http://www.scmp.com/news/china/article/1302852/beijing-weighing-large-fines-against-glaxosmithkline Wednesday, 04 September, 2013, 10:02am Toh Han Shih hanshih.toh@scmp.com This article appeared in the South China Morning Post print edition as Beijing weighing large fines against GlaxoSmithKline   The central government is considering … Lees meer

Nieuwsbrief